A new study of Antigenics’ Oncophage cancer vaccine demonstrated increased survival in patients with glioma brain cancer. There was an increased survival of 10.5 months, and one patient lived 2 ½ years. This is compared to 6.5 months for treatment without Oncophage.
Cancer vaccines like Oncophage have really struggled as the FDA has pulled the rug out from under a number of companies. However, drugs like Oncophage are demonstrating survival and will eventually receive FDA approval.
See
Antigenics Oncophage Gets Mixed Results
Cancer vaccines like Oncophage have really struggled as the FDA has pulled the rug out from under a number of companies. However, drugs like Oncophage are demonstrating survival and will eventually receive FDA approval.
See Antigenics Oncophage Gets Mixed Results